Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD  |  Issue: May 2014  |  May 1, 2014

Clinical Conceptualization of the Natural History of axSpA: An Emerging Model
click for large version
Figure 1: Clinical Conceptualization of the Natural History of axSpA: An Emerging Model
Here, the course of axial SpA is compared to the course of a river. A) Some people may be genetically predisposed to develop axial SpA but may never develop any clinical manifestations of the condition or may have a subclinical disease. B) According to the recent NHANES study (2009–2010), inflammatory back pain is found in 6% of U.S. population, but only a small percentage of those will develop C) nonradiographic axial SpA (nr-axSpA). D) A small percentage of these people may have a spontaneous remission, and E) some may have a quiescent disease course. F) Studies have shown that up to 12% of nr-axSpA patients develop ankylosing spondyloarthritis (radiographic sacroiliitis) in two years; whereas, others may continue as G) nr-axSpA. Not all ankylosing spondylitis patients have a progressive course, either. Some progress to develop long-term complications H), and others may have a relatively benign but chronic course I). Adapted from van Vollenhoven RF. Nat Rev Rheumatol. 2011 Apr;7(4):205–215.

MRI of the sacroiliac (SI) joints has emerged as the imaging investigation of choice for patients with suspected axSpA who do not have X-ray evidence of sacroiliitis. On T2-weighted fat-suppressed sequences (called STIR sequences) of the MRI, active inflammatory lesions of osteitis are seen as bone marrow edema (BME). MRI can also detect other lesions, such as synovitis, enthesitis and capsulitis, associated with SpA. Among these, the clear presence of a single osteitis lesion on two consecutive slices or two osteitis lesions on a single MRI slice is considered essential for defining active sacroiliitis.8 Structural damage lesions, such as sclerosis, erosions, fat deposition and ankylosis can also be detected by MRI on T1-weighted images.9

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although an MRI scan of the SI joints is progressively used in the early diagnosis of nr-axSpA, it has several limitations. The BME seen on STIR images used to diagnose sacroiliitis can also be seen in normal adults, young patients with trauma and older patients with degenerative arthritis of the SI joints. Also, because AS patients have intermittent sacroiliac joint inflammation, the absence of BME cannot rule out axSpA. Signs of structural damage on T1-weighted images of the SI joints described above could increase the specificity of the diagnosis,9 although the exact location for structural damage lesions for diagnosis and classification is less clear.

Finally, as with every other diagnosis in rheumatology, expensive investigations can only supplement and not replace the thoughtfulness that goes into making an accurate clinical diagnosis. Ordering HLA-B27 or an MRI scan of the SI joints in patients who have no other features of SpA or whose back pain started after the age of 45 should be avoided.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Prevalence

Axial spondyloarthritis may be as prevalent as rheumatoid arthritis, and nr-axSpA has disease burden comparable to AS.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Ankylosing Spondylitisanti-inflammatoryaxial skeletal inflammationaxial spondyloarthritis (SpA)DrugsepidemiologyimagingPainpatient careradiographResearchrheumatologistrituximabterminologyTofacitinib

Related Articles
    Andrew Brookes / Image Source on Offset

    Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5

    February 10, 2022

    Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options; others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

    Nelosa/shutterstock.com

    Men, Women & Medical Differences in Axial Spondyloarthropathy

    October 24, 2019

    Historically, ankylosing spondylitis was considered mainly a male disease. But it has become evident this predominance is not as great as previously believed. Here we discuss recent developments in the area, including potential differences between the sexes in symptom and disease burden, immunological and genetic background, diagnostic delay, treatment response and ongoing research questions. Medical…

    How Do Axial SpA & PsA with Axial Involvement Differ?

    February 2, 2022

    The differences between axial spondyloarthropathy (axSpA) and axial involvement in psoriatic arthritis (axPsA) have clinical and therapeutic implications. Three experts discussed the distinctions during ACR Convergence 2021.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences